Goldman Sachs’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
|
|||||
|
2025
Q1 | $216K | Sell |
|
|||||
|
2024
Q4 | $377K | Buy |
|
|||||
|
2024
Q3 | $362K | Buy |
|
|||||
|
2024
Q2 | $124K | Sell |
|
|||||
|
2024
Q1 | $1.29M | Buy |
|
|||||
|
2023
Q4 | $441K | Buy |
|
|||||
|
2023
Q3 | $238K | Buy |
|
|||||
|
2023
Q2 | $65.3K | Sell |
|
|||||
|
2023
Q1 | $172K | Buy |
|
|||||
|
2022
Q4 | $91.8K | Sell |
|
|||||
|
2022
Q3 | $227K | Sell |
|
|||||
|
2022
Q2 | $131K | Sell |
|
|||||
|
2022
Q1 | $1.31M | Buy |
|
|||||
|
2021
Q4 | $2.19M | Buy |
|
|||||
|
2021
Q3 | $946K | Buy |
|